CLSD
Price
$0.79
Change
+$0.02 (+2.60%)
Updated
Jun 6 closing price
Capitalization
61.12M
70 days until earnings call
INBX
Price
$13.92
Change
+$1.03 (+7.99%)
Updated
Jun 6 closing price
Capitalization
201.5M
71 days until earnings call
Interact to see
Advertisement

CLSD vs INBX

Header iconCLSD vs INBX Comparison
Open Charts CLSD vs INBXBanner chart's image
Clearside Biomedical
Price$0.79
Change+$0.02 (+2.60%)
Volume$226.42K
Capitalization61.12M
Inhibrx Biosciences
Price$13.92
Change+$1.03 (+7.99%)
Volume$91.39K
Capitalization201.5M
CLSD vs INBX Comparison Chart
Loading...
CLSD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
INBX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CLSD vs. INBX commentary
Jun 09, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CLSD is a Buy and INBX is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 09, 2025
Stock price -- (CLSD: $0.79 vs. INBX: $12.91)
Brand notoriety: CLSD and INBX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CLSD: 197% vs. INBX: 25%
Market capitalization -- CLSD: $61.12M vs. INBX: $186.59M
CLSD [@Biotechnology] is valued at $61.12M. INBX’s [@Biotechnology] market capitalization is $186.59M. The market cap for tickers in the [@Biotechnology] industry ranges from $334.5B to $0. The average market capitalization across the [@Biotechnology] industry is $2.25B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CLSD’s FA Score shows that 0 FA rating(s) are green whileINBX’s FA Score has 1 green FA rating(s).

  • CLSD’s FA Score: 0 green, 5 red.
  • INBX’s FA Score: 1 green, 4 red.
According to our system of comparison, INBX is a better buy in the long-term than CLSD.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CLSD’s TA Score shows that 4 TA indicator(s) are bullish while INBX’s TA Score has 5 bullish TA indicator(s).

  • CLSD’s TA Score: 4 bullish, 4 bearish.
  • INBX’s TA Score: 5 bullish, 2 bearish.
According to our system of comparison, INBX is a better buy in the short-term than CLSD.

Price Growth

CLSD (@Biotechnology) experienced а -6.81% price change this week, while INBX (@Biotechnology) price change was -1.90% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.11%. For the same industry, the average monthly price growth was +10.01%, and the average quarterly price growth was -2.16%.

Reported Earning Dates

CLSD is expected to report earnings on Aug 18, 2025.

INBX is expected to report earnings on Aug 19, 2025.

Industries' Descriptions

@Biotechnology (+4.11% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
INBX($202M) has a higher market cap than CLSD($61.1M). INBX YTD gains are higher at: -16.169 vs. CLSD (-17.200). INBX has higher annual earnings (EBITDA): 1.7B vs. CLSD (-22.23M). INBX has more cash in the bank: 153M vs. CLSD (23.6M). CLSD has less debt than INBX: CLSD (785K) vs INBX (8.05M). CLSD has higher revenues than INBX: CLSD (7.7M) vs INBX (200K).
CLSDINBXCLSD / INBX
Capitalization61.1M202M30%
EBITDA-22.23M1.7B-1%
Gain YTD-17.200-16.169106%
P/E RatioN/A0.12-
Revenue7.7M200K3,852%
Total Cash23.6M153M15%
Total Debt785K8.05M10%
FUNDAMENTALS RATINGS
CLSD: Fundamental Ratings
CLSD
OUTLOOK RATING
1..100
13
VALUATION
overvalued / fair valued / undervalued
1..100
90
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
80
P/E GROWTH RATING
1..100
77
SEASONALITY SCORE
1..100
85

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CLSDINBX
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bullish Trend 12 days ago
80%
Bearish Trend 12 days ago
85%
Momentum
ODDS (%)
Bearish Trend 12 days ago
90%
Bullish Trend 12 days ago
77%
MACD
ODDS (%)
Bearish Trend 12 days ago
90%
Bullish Trend 12 days ago
77%
TrendWeek
ODDS (%)
Bearish Trend 12 days ago
87%
Bearish Trend 12 days ago
84%
TrendMonth
ODDS (%)
Bearish Trend 12 days ago
86%
Bullish Trend 12 days ago
80%
Advances
ODDS (%)
Bullish Trend 21 days ago
82%
Bullish Trend 19 days ago
80%
Declines
ODDS (%)
Bearish Trend 12 days ago
88%
Bearish Trend 26 days ago
84%
BollingerBands
ODDS (%)
Bullish Trend 12 days ago
75%
Bullish Trend 12 days ago
74%
Aroon
ODDS (%)
Bullish Trend 12 days ago
90%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
CLSD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
INBX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AAPL200.420.21
+0.10%
Apple
SPY587.73-3.42
-0.58%
SPDR® S&P 500® ETF
BTC.X107802.330000-1192.312500
-1.09%
Bitcoin cryptocurrency
TSLA356.90-5.99
-1.65%
Tesla
GME31.21-3.80
-10.85%
GameStop Corp

CLSD and

Correlation & Price change

A.I.dvisor tells us that CLSD and ACLX have been poorly correlated (+28% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that CLSD and ACLX's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CLSD
1D Price
Change %
CLSD100%
-4.04%
ACLX - CLSD
28%
Poorly correlated
-1.29%
INBX - CLSD
28%
Poorly correlated
-1.68%
ATRA - CLSD
27%
Poorly correlated
+4.07%
JAZZ - CLSD
26%
Poorly correlated
-2.24%
IKNA - CLSD
26%
Poorly correlated
-2.13%
More

INBX and

Correlation & Price change

A.I.dvisor tells us that INBX and ARQT have been poorly correlated (+32% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that INBX and ARQT's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To INBX
1D Price
Change %
INBX100%
-1.68%
ARQT - INBX
32%
Poorly correlated
-3.96%
CHRS - INBX
31%
Poorly correlated
+2.54%
ADPT - INBX
31%
Poorly correlated
+0.11%
ELVN - INBX
31%
Poorly correlated
+0.50%
IMTX - INBX
30%
Poorly correlated
+4.26%
More